Sagard Healthcare Partners and funds managed by Oaktree Capital Management, L.P. /
Athenex, Inc.
Athenex agrees to sell Klisyri revenue interests
- Valuation
- $85m
- Stage
- Agreement signed
What happened
Athenex, Inc. signed an agreement with Sagard Healthcare Partners and funds managed by Oaktree Capital Management, L.P. to sell U.S. and European royalty and milestone interests in Klisyri.
The transaction is valued at $85 million. Athenex said approximately $80 million of proceeds will go toward partially paying down existing debt and operating the business, with $5 million placed into escrow.
The source
Everything on this page comes from the source below.
Athenex agrees to sell Klisyri revenue interests
This document is the source for the companies, stage, figure and people on this page.
Original filingUnlock with ProTimeline
Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.
Published by the source
The source this page is built from.
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Request accessAlready invited? Sign in
Carrywatch Pro is by invitation. An invite lets you buy Pro.
By email · Weekly